Abstract
The bones are one of the most common sites for metastatic cancer spread. Unfortunately, there is no current known cure for many people affected by bone metastasis. Therefore, the treatment intent for radiotherapy remains a palliative objective, whereby treatments are meant to provide pain relief and alleviate symptoms. However, some debate has arisen in recent decades regarding the most appropriate dose prescription pertaining to dose protraction and fractionation. By delivering a larger dose in fewer fractions, patients can spend less time at the hospital and more time with loved ones. Additionally, many dose prescriptions were prioritized to be shortened during the COVID-19 pandemic, which may offer retrospective data on the treatment outcomes from providing shortened courses of radiotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
